Voyager Technologies to Manage Cancer Research Experiment on ISS

This mission aims to test the SymphNode device, which is intended to enhance the body's immune response in immunosuppressive conditions by activating a patient’s T cells to combat cancer.

As part of its responsibilities, Voyager will provide mission management services, including the preparation, integration, operation, and return of the experiment.

The company will modify Symphony Biosciences’ sample hardware for use with ISS equipment and facilitate the safety review process required by NASA.

Additionally, Voyager will manage the integration and storage of materials prior to launch.

Once in orbit, Voyager's mission managers will supervise operations from their mission control facility, including supporting incubation and fluorescence monitoring while assisting astronauts with the experiment on the ISS.

After the conclusion of the study, Voyager will handle the return of samples and data, along with post-flight mission reporting.

The research aims to investigate if immune cells trained with SymphNode can effectively respond to cancer in the unique microgravity environment of the ISS.

The study seeks to replicate previous in vitro research conducted on Earth using human T cells and tumor cells, with a focus on how microgravity may facilitate the formation of complex tumor structures not easily observable in standard Earth-based cultures.

This experimental environment could provide valuable insights into immune cell-tumor interactions and assess the efficacy of approaches like SymphNode in enhancing immune responses.

The contract demonstrates the ongoing utilization of low-Earth orbit for biotechnology and pharmaceutical research.

Voyager boasts two decades of experience with over 1,400 missions and is preparing to transition from ISS research to future commercial platforms, including Starlab, a planned commercial space station.

Voyager Technologies operates in defense technology and space solutions, encompassing areas such as propulsion, energetics, advanced electronics, mission management, and exploration.

Scott Rodriguez, Vice President of Government Programs at Voyager Technologies, emphasized the importance of their mission management service in facilitating breakthrough research, stating that microgravity enhances cancer research by presenting tumor cells in intricate three-dimensional formations that are challenging to replicate in Earth cultures.